Trial Profile
Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS (GLUT-HEP)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Triheptanoin (Primary)
- Indications De Vivo disease
- Focus Therapeutic Use
- Acronyms GLUT-HEP
- 24 Aug 2021 Status changed to completed.
- 14 Nov 2019 Status changed from recruiting to discontinued.
- 30 Apr 2015 Planned End Date changed from 1 Nov 2014 to 1 Apr 2018 as reported by ClinicalTrials.gov record.